Singapore markets closed

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8500-0.0300 (-1.04%)
At close: 04:00PM EDT
2.8500 0.00 (0.00%)
After hours: 04:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 345.71M
Enterprise value 170.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.98
Price/book (mrq)9.37
Enterprise value/revenue 4.62
Enterprise value/EBITDA -1.03

Trading information

Stock price history

Beta (5Y monthly) 1.51
52-week change 3-34.93%
S&P500 52-week change 321.08%
52-week high 39.6200
52-week low 30.8010
50-day moving average 34.3892
200-day moving average 32.5649

Share statistics

Avg vol (3-month) 32.24M
Avg vol (10-day) 31.9M
Shares outstanding 5121.3M
Implied shares outstanding 6121.3M
Float 864.31M
% held by insiders 11.33%
% held by institutions 195.29%
Shares short (15 Apr 2024) 410.58M
Short ratio (15 Apr 2024) 45.08
Short % of float (15 Apr 2024) 49.49%
Short % of shares outstanding (15 Apr 2024) 48.72%
Shares short (prior month 15 Mar 2024) 48.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-195.57%

Management effectiveness

Return on assets (ttm)-38.13%
Return on equity (ttm)-266.24%

Income statement

Revenue (ttm)36.85M
Revenue per share (ttm)0.32
Quarterly revenue growth (yoy)-27.10%
Gross profit (ttm)N/A
EBITDA -169.44M
Net income avi to common (ttm)-171.67M
Diluted EPS (ttm)-1.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)209.08M
Total cash per share (mrq)1.72
Total debt (mrq)33.83M
Total debt/equity (mrq)91.67%
Current ratio (mrq)3.36
Book value per share (mrq)0.31

Cash flow statement

Operating cash flow (ttm)-168.88M
Levered free cash flow (ttm)-85.71M